z-logo
open-access-imgOpen Access
Human MutY homolog induces apoptosis in etoposide-treated HEK293 cells
Author(s) -
Soo-Hyun Hahm,
Ji Hyung Chung,
Lia Agustina,
SE-HEE HAN,
InSoo Yoon,
Jong-Hwa Park,
LinWoo Kang,
JinWoo Park,
JONG JOO NA,
Ye Sun Han
Publication year - 2012
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2012.921
Subject(s) - apoptosis , etoposide , gene knockdown , cell cycle , cancer research , dna damage , microbiology and biotechnology , ataxia telangiectasia , oncogene , hek 293 cells , biology , chemistry , cell culture , biochemistry , dna , genetics , chemotherapy
Etoposide (ETP) treatment of ataxia telangiectasia mutated (ATM) and Rad3-related protein (ATR)-, topoisomerase-binding protein-1 (TopBP1) and human MutY homolog (hMYH)-depleted cells results in a significant reduction in apoptotic signaling. The association between ATR or TopBP1 and hMYH increased following ETP treatment. In hMYH knockdown cells, the interaction between ATR and TopBP1 decreased following ETP treatment. We suggest that hMYH functions as a sensor of ETP-induced apoptosis. The results suggest that in the absence of hMYH, cells are unable to recognize the damage signal and the ATR pathway is not activated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom